tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GMAB Stock Latest News

AbbVie and Genmab’s Epcoritamab Trial: A Potential Game-Changer for B-NHL Treatment
Company AnnouncementsAbbVie and Genmab’s Epcoritamab Trial: A Potential Game-Changer for B-NHL Treatment
19h ago
ABBV
GMAB
Genmab’s GEN1160 Study: A New Hope for Advanced Cancer Treatment
PremiumCompany Announcements
Genmab’s GEN1160 Study: A New Hope for Advanced Cancer Treatment
19h ago
GMAB
Genmab Reports Strong DARZALEX® Sales for Q2 2025
PremiumCompany Announcements
Genmab Reports Strong DARZALEX® Sales for Q2 2025
3d ago
6K
GMAB
Genmab reports Q2 worldwide net sales of Darzalex $3.54B
PremiumThe Fly
Genmab reports Q2 worldwide net sales of Darzalex $3.54B
3d ago
JNJ
GMAB
Abbvie and Genmab’s Promising Study on Epcoritamab for Lymphoma: A Financial Perspective
PremiumCompany Announcements
Abbvie and Genmab’s Promising Study on Epcoritamab for Lymphoma: A Financial Perspective
5d ago
ABBV
GMAB
Genmab’s Tisotumab Vedotin Study: A Potential Game-Changer in Cervical Cancer Treatment
PremiumCompany AnnouncementsGenmab’s Tisotumab Vedotin Study: A Potential Game-Changer in Cervical Cancer Treatment
8d ago
GMAB
Genmab and BioNTech’s Immunoradiotherapy Study: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Genmab and BioNTech’s Immunoradiotherapy Study: A Potential Game-Changer in Cancer Treatment
9d ago
BNTX
GMAB
AbbVie and Genmab’s Epcoritamab Trial: A Promising Update for B-NHL Treatment
Premium
Company Announcements
AbbVie and Genmab’s Epcoritamab Trial: A Promising Update for B-NHL Treatment
9d ago
ABBV
GMAB
Genmab’s Phase 3 Trial: A Potential Game-Changer for Lung Cancer Treatment?
PremiumCompany Announcements
Genmab’s Phase 3 Trial: A Potential Game-Changer for Lung Cancer Treatment?
9d ago
GMAB
Genmab’s New Study on Advanced Melanoma: What Investors Need to Know
PremiumCompany Announcements
Genmab’s New Study on Advanced Melanoma: What Investors Need to Know
9d ago
GMAB
Genmab’s Phase 2 Study on Tisotumab Vedotin: A Potential Game-Changer for Solid Tumors
PremiumCompany Announcements
Genmab’s Phase 2 Study on Tisotumab Vedotin: A Potential Game-Changer for Solid Tumors
9d ago
GMAB
Genmab and BioNTech’s Promising Cancer Trial: A Potential Game-Changer?
PremiumCompany Announcements
Genmab and BioNTech’s Promising Cancer Trial: A Potential Game-Changer?
9d ago
BNTX
GMAB
GEN1042 Safety Trial: A Promising Step in Cancer Treatment
PremiumCompany AnnouncementsGEN1042 Safety Trial: A Promising Step in Cancer Treatment
9d ago
BNTX
GMAB
AbbVie and Genmab’s Promising Phase 3 Study for DLBCL: A Potential Game-Changer
Premium
Company Announcements
AbbVie and Genmab’s Promising Phase 3 Study for DLBCL: A Potential Game-Changer
9d ago
ABBV
GMAB
Genmab’s GEN3014 Trial: A Potential Game-Changer in Hematologic Malignancies
Premium
Company Announcements
Genmab’s GEN3014 Trial: A Potential Game-Changer in Hematologic Malignancies
9d ago
GMAB
Genmab’s GEN1057 Trial: A New Frontier in Cancer Treatment
PremiumCompany Announcements
Genmab’s GEN1057 Trial: A New Frontier in Cancer Treatment
9d ago
GMAB
Genmab’s New Study on GEN1107: Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
Genmab’s New Study on GEN1107: Potential Game-Changer in Cancer Treatment?
9d ago
GMAB
Genmab and BioNTech’s GEN1042 Study: A New Hope for Cancer Treatment?
PremiumCompany Announcements
Genmab and BioNTech’s GEN1042 Study: A New Hope for Cancer Treatment?
9d ago
BNTX
GMAB
Genmab and BioNTech’s GEN1056 Study: A New Hope for Advanced Solid Tumors
PremiumCompany Announcements
Genmab and BioNTech’s GEN1056 Study: A New Hope for Advanced Solid Tumors
9d ago
BNTX
GMAB
Genmab’s GEN1286 Study: A New Hope for Advanced Solid Tumors
PremiumCompany AnnouncementsGenmab’s GEN1286 Study: A New Hope for Advanced Solid Tumors
9d ago
GMAB
AbbVie and Genmab’s Phase 3 Trial: A New Hope for DLBCL Treatment?
Premium
Company Announcements
AbbVie and Genmab’s Phase 3 Trial: A New Hope for DLBCL Treatment?
9d ago
ABBV
GMAB
Pfizer and Genmab’s Tivdak Study: A Closer Look at Ocular Safety in Cervical Cancer Treatment
Premium
Company Announcements
Pfizer and Genmab’s Tivdak Study: A Closer Look at Ocular Safety in Cervical Cancer Treatment
9d ago
PFE
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >